-
Repligen Corporation (RGEN $130.19)
- $130.19 Cap: $7.52B
- View RGEN Profile
- View Questions on RGEN
Detailed Quote
Questions on this company?
Become a Member
Company Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Biogen Inc. (BIIB $134.21)
- $134.21 Fwd P/E: 13.37X Cap: $19.66B
- View BIIB Profile
- View Questions on BIIB
-
Intuitive Surgical Inc. (ISRG $512.06)
- $512.06 Fwd P/E: 77.02X Cap: $188.54B
- View ISRG Profile
- View Questions on ISRG
-
AbbVie Inc. (ABBV $192.45)
- $192.45 Fwd P/E: 83.33X Cap: $344.44B
- View ABBV Profile
- View Questions on ABBV
-
Eli Lilly and Company (LLY $793.01)
- $793.01 Fwd P/E: 64.33X Cap: $751.56B
- View LLY Profile
- View Questions on LLY
-
Repligen Corporation (RGEN $130.19)
- $130.19 Cap: $7.52B
- View RGEN Profile
- View Questions on RGEN
Q: Repligen is trading close to the 52-week low and would welcome your analysis of their recent operating performance and market potential looking forward. Post-pandemic and mindful of competitors in the same space does their stock have any opportunity to excel in the coming year, and if held as a position in a long-term growth portfolio, could you please rank the appeal of Repligen in descending order versus your go-to favorites in the same general space. Thanks kindly for your thoughts.
-
Shopify Inc. Class A Subordinate Voting Shares (SHOP $153.42)
- $153.42 Fwd P/E: 94.42X Cap: $199.04B
- View SHOP Profile
- View Questions on SHOP
- View Reports on SHOP
-
MercadoLibre Inc. (MELI $2,387.45)
- $2,387.45 Fwd P/E: 59.09X Cap: $121.03B
- View MELI Profile
- View Questions on MELI
-
Etsy Inc. (ETSY $57.87)
- $57.87 Fwd P/E: 42.14X Cap: $6.06B
- View ETSY Profile
- View Questions on ETSY
-
Roku Inc. (ROKU $88.99)
- $88.99 Cap: $13.23B
- View ROKU Profile
- View Questions on ROKU
-
Teladoc Health Inc. (TDOC $8.32)
- $8.32 Cap: $1.54B
- View TDOC Profile
- View Questions on TDOC
-
Redfin Corporation (RDFN)
-
Repligen Corporation (RGEN $130.19)
- $130.19 Cap: $7.52B
- View RGEN Profile
- View Questions on RGEN
-
Datadog Inc. (DDOG $137.37)
- $137.37 Fwd P/E: 296.31X Cap: $47.44B
- View DDOG Profile
- View Questions on DDOG
-
Palantir Technologies Inc. (PLTR $142.10)
- $142.10 Fwd P/E: 619.57X Cap: $336.28B
- View PLTR Profile
- View Questions on PLTR
-
AbCellera Biologics Inc. (ABCL $4.01)
- $4.01 Cap: $1.25B
- View ABCL Profile
- View Questions on ABCL
Q: Good day. A little over 1 year ago I allocated about 5% of my portfolio to the high growth/risk stocks. Needles to stay it hasn't worked out as expected. At this stage I am hoping that you can give me insight what the future holds for these companies as an investment. Which should be sold and subsequently move the funds moved into the keepers.
Deduct as many credits as you feel appropriate.
Much appreciated
Deduct as many credits as you feel appropriate.
Much appreciated
-
Veeva Systems Inc. Class A (VEEV $275.89)
- $275.89 Fwd P/E: 59.8X Cap: $45.08B
- View VEEV Profile
- View Questions on VEEV
-
Repligen Corporation (RGEN $130.19)
- $130.19 Cap: $7.52B
- View RGEN Profile
- View Questions on RGEN
Q: Hello 5i
I have owned RGEN for several years.
Could you tell me how you would rank it against its peers? Is there a name you prefer more and if so why?
Thank you so much!!
Dave
I have owned RGEN for several years.
Could you tell me how you would rank it against its peers? Is there a name you prefer more and if so why?
Thank you so much!!
Dave
Insiders
Share Information
SEC Filings
News and Media